POST Online Media Lite Edition


Norgine announces senior management changes

Christian Fernsby |
Amsterdam, Netherlands - Norgine B.V., a specialist pharmaceutical company, announces that Christopher Bath has been appointed chief executive officer effective 1 January 2022.

Article continues below

Mr. Bath, who is currently Norgine's Chief Operating Officer, will continue to report to Peter Stein, who is stepping down as CEO after 35 years in the role to take on the role of Executive Chairman.

Mr. Bath joined Norgine in 2014 from Shire plc, where he was Head of M&A.

His career in healthcare started at Rothschild in 2000, where he spent 10 years in the healthcare investment banking team.

Mr. Bath is a Chartered Accountant and holds a degree in Physics from Lady Margaret Hall, Oxford.


Just Eat Takeaway chairman Adriaan Nühn resigns
Micreos appoints Joost Goderie as CFO and member of the board
CLEVR appoints Michael Winfield as UK MD
Micreos appoints Matt Regan as CEO of its pharmaceutical business
Koert Grasveld joined TerraPay as vice president, payments